Bioinformatics analysis of human kallikrein 5 (KLK5) expression in metaplastic triple‐negative breast cancer
Abstract Background Metaplastic breast carcinoma (MBC) is a rare breast cancer subtype; most cases are triple‐negative breast cancers (TNBCs) and are poorly responsive to conventional systemic therapy. Few potential diagnostic and prognostic markers for distinguishing between metaplastic TNBC and no...
Main Authors: | Yue Song, Guiying Bai, Xiaoqing Li, Liyan Zhou, Yiran Si, Xiaohui Liu, Yilin Deng, Yehui Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-10-01
|
Series: | Cancer Innovation |
Subjects: | |
Online Access: | https://doi.org/10.1002/cai2.96 |
Similar Items
-
A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA Expression
by: Yueyang Liu, et al.
Published: (2022-09-01) -
Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients
by: Weiwei Gong, et al.
Published: (2020-02-01) -
Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer
by: Weiwei Gong, et al.
Published: (2020-10-01) -
Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic Marker
by: Ai Sato, et al.
Published: (2023-05-01) -
Down-regulation of kallikrein-related peptidase 5 (<it>KLK5</it>) expression in breast cancer patients: a biomarker for the differential diagnosis of breast lesions
by: Avgeris Margaritis, et al.
Published: (2011-05-01)